Covid: the invention of a start-up in Montpellier to respect the cold chain in vaccine transportation

Transport of the vaccine against COVID-19 

France 3 Occitanie presents the association of a pharmaceutical isothermal bag with a traceability of temperature maintenance:
 
A temperature recorder from KOOVEA combined with MedicalCase medical coolers from COLD & CO.
 
Millions of doses of Covid vaccines are currently being shipped around the world. This is a challenge for transporters who must respect the cold chain. In Montpellier, a start-up company has developed a technology that addresses this problem and its order book is exploding.
 
Minus 70°C: that’s the temperature above which Pfizer/BioNTech and Moderna’s anti-Covid vaccines must not rise, otherwise they will lose their immunity and suffer side effects.
 

Case of MedicalCase 12L

Carrying case for the anti-Covid vaccine equipped with the temperature tracking sensor of the Montpellier start-up Koovea – © François Jobard, France 3 Occitanie.

From then on, their routing becomes a real challenge for transporters: how to ensure that the cold chain is respected ? The box invented by a Montpellier start-up in 2019 makes it possible. Result: for several weeks, the company Koovea has noticed a sharp increase in its orders.

Cold and humidity have complicated the design of the box 

 

This device measures only a few centimeters. Connected and intelligent, it slips into the vaccine’s carrying case and allows the traceability of the temperature of sensitive products down to minus 200 degrees, thanks to an innovative process that gave Romain Penot, electronic engineer at Koovea, a hard time:

« The conditions of transport and storage of the vaccine are extreme: intense cold, humidity… The electronics, the plastics, the battery: all the material suffers. Yet we manage to achieve three to five years of autonomy despite the very low temperatures, but that was one of the biggest difficulties in the design. »

Romain Penot, electronic engineer at Koovea

 

 

Temperature tracking smartphone application

 

Because the covid-19 vaccine must be stored at minus 70 degrees, a tolerance of plus or minus 10 degrees is accepted. Beyond that, an alert is automatically sent to the carrier’s phone on which the temperatures of each refrigerated container are displayed, so that he can act to preserve the viability of the product, as explained by Yohann Caboni, director and co-founder of Koovea:

« We developed a whole system with sensors, keywords, a computer interface and an application that allows for real-time tracking of temperature, specifications and location of all Covid vaccine-type health products. »

Yohann Caboni, director and co-founder of Koovea

 

Activity up 10 to 20%.

 

Every week, 500,000 doses of vaccine are sent to France. The pace should accelerate from February.

In this context, the Montpellier-based start-up, which has customers all over the world, has seen its activity increase by 10 to 20% in recent weeks and this growth should continue.

Any questions ?

By submitting this form, you authorize this website to store the information submitted in order to respond to you.

Protecting temperature-sensitive chemicals: when logistics becomes a key factor in performance

In the world of specialty chemicals, formulation stability does not end with their design in the laboratory. Transportation, often perceived as a standard logistical link, becomes a critical issue when products are heat-sensitive. This is the case for a French manufacturer specializing in the distribution of varnishes, paints, and resins for finishing flexible materials. It

Protecting temperature-sensitive chemicals: when logistics becomes a key factor in performance Lire la suite »

Transport at controlled ambient temperature between +18°C and +25°C : a logistical challenge for medical devices

The thermal challenge +18°C to +25°C at the heart of medical logistics In the field of the transport of medical devices of in vitro diagnostics (IVD), some entities face a particular challenge: maintaining a strictly controlled temperature between 18°C and 25°C, regardless of the season. In both winter and summer, this requirement for thermal stability

Transport at controlled ambient temperature between +18°C and +25°C : a logistical challenge for medical devices Lire la suite »

chambre froide mobile XXL caisse croco

COLD & CO brings FLEXIBILITY – COLDNEWS

 In the air of time, the custom-made isothermal container CarryTemp XL6 of COLD & CO offers a capacity of 6 crocodile boxes, and answers the needs of logisticians.  The CarryTemp XL6 model allows for temperature-controlled transport, up to tri-temperature, without affecting the integrity of the standard utility vehicle. The enclosure is equipped with a self-contained passive cooling system

COLD & CO brings FLEXIBILITY – COLDNEWS Lire la suite »

Transport at controlled ambient temperatures between +18°C and +25°C: a logistical challenge for medical devices

The +18°C to +25°C thermal challenge at the heart of medical logistics When it comes to transporting in vitro diagnostic medical devices (IVDMDs), certain entities face a very specific challenge: maintaining a strictly controlled temperature between 18°C and 25°C, whatever the season. In winter as in summer, this requirement for thermal stability is crucial to

Transport at controlled ambient temperatures between +18°C and +25°C: a logistical challenge for medical devices Lire la suite »

La Poste decarbonizes its urban logistics 

During the SITL 2023 (International Transport and Logistics Week), La Poste, through the voice of its director of urban logistics (La Poste Courrier et Colis) Jean-Louis Carrasco, explained its plan to completely decarbonize its urban logistics by 2050. La Poste, which is the national postal service of France, is indeed seeking to reduce its carbon

La Poste decarbonizes its urban logistics  Lire la suite »

A messenger RNA vaccine against COVID 19, what impact on the cold chain?

Since November 9, several laboratories have announced the development of a vaccine that is more than 90% effective. Pfizer-BioNtech laboratories present their first results obtained on a messenger RNA (mRNA) vaccine. What is the principle of this vaccine? What impact on its cold chain ? Historical vaccines with infectious agents Historically, the first vaccines were

A messenger RNA vaccine against COVID 19, what impact on the cold chain? Lire la suite »